Hepatocellular Carcinoma
📧 Sign up to get email alerts when something new happens for Hepatocellular Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-09-25Clinical Trial Update: Adjuvant Immune Checkpoint Inhibitors in Postoperative Hepatocellular Carcinoma
A completed clinical trial update assessing adjuvant immune checkpoint inhibitors in patients after hepatocellular carcinoma surgery.
-
CLINICAL_TRIALS trial_result · 2024-09-24Clinical Trial Update: Study Efficacy and Safety of INC280 in Patients With Advanced Hepatocellular Carcinoma. [Phase 2]
A Phase 2 trial of INC280 in advanced hepatocellular carcinoma with c-MET dysregulation was terminated; results assessing efficacy and safet…
-
CLINICAL_TRIALS research · 2024-09-23Clinical Trial Update: Prognosis Stratification for Advanced HCC Receiving TACE with PD-1/PD-L1 Inhibitors and Molecular Target Therapies
This clinical trial update shows a recruiting study at Zhongda Hospital evaluating prognosis-based stratification for advanced hepatocellula…
-
CLINICAL_TRIALS research · 2024-09-23Clinical Trial Update: bTAE-HAIC Combined With System Therapy for Intermediate-advanced Huge HCC [NA]
A clinical trial is evaluating balloon-occluded transarterial embolization with hepatic arterial infusion chemotherapy (bTAE-HAIC) plus syst…
-
CLINICAL_TRIALS research · 2024-09-23Clinical Trial Update: Anti-cancer Potentiality of Saffron Against Hepatocellular Carcinoma [Phase 4]
A Phase 4 clinical trial from Ain Shams University is evaluating saffron extract as a potential treatment for hepatocellular carcinoma, whic…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-09-23Clinical Trial Update: Study of Palliative Radiotherapy for Symptomatic Hepatocellular Carcinoma and Liver Metastases [NA]
Completed clinical trial evaluating palliative radiotherapy for symptomatic hepatocellular carcinoma and liver metastases, with results post…
-
CLINICAL_TRIALS other · 2024-09-23Clinical Trial Update: mFOLFOX7 Plus Camrelizumab and Apatinib in BCLC Stage A/B Hepatocellular Carcinoma Patients Beyond Milan Criteria [Phase 2]
Phase 2 clinical trial update for mFOLFOX7 plus Camrelizumab and Apatinib in non-resectable hepatocellular carcinoma beyond Milan criteria, …
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Adoptive Transfer of iNKT Cells for Treating Patients With Relapsed/Advanced HCC [Phase 1]
Phase 1 study of adoptive transfer of invariant natural killer T (iNKT) cells for relapsed or advanced hepatocellular carcinoma has complete…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Efficacy and Safety of IBI310 Combined with Sintilimab in Patients with Advanced Hepatocellular Carcinoma [Phase 1]
A Phase 1 trial evaluating the efficacy and safety of combining IBI310 with sintilimab in patients with advanced hepatocellular carcinoma ha…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: PSMA PET/MRI or PSMA PET/CT for Evaluation of Liver Cancer [EARLY_Phase 1]
An early-phase 1 trial evaluating PSMA-targeted PET imaging using PSMA PET/MRI or PSMA PET/CT for hepatocellular carcinoma has completed. Th…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Measuring the Density of Iodine in Lipiodol Depositions: Detecting an Invisible Residual Tumor After Conventional Transarterial Chemoembolization for Hepatocellular Carcinoma [NA]
This clinical trial update describes a study to measure iodine density in Lipiodol deposits to detect an invisible residual tumor after conv…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: The Study of KN046 in Combination With Lenvatinib in Advanced Hepatocellular Carcinoma [Phase 2]
Phase 2 study of KN046 in combination with lenvatinib for advanced hepatocellular carcinoma has completed; results are not described in this…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: To Quantify the Impact of Addition of the GAAD Score to Imaging in Patients with Chronic Liver Disease Eligible for HCC Surveillance.
A clinical trial is evaluating whether adding the GAAD Score to imaging improves hepatocellular carcinoma surveillance in patients with chro…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: "cindilizumab + Bevacizumab + Coenzyme I for Injection" in Unresectable Hepatocellular Carcinoma [Phase 4]
Phase 4 clinical trial evaluating a combination of cindilizumab, bevacizumab, and Coenzyme I for Injection in unresectable hepatocellular ca…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Second-line Systemic Therapy Combined with SBRT for HCC with Oligoprogression After Standard First-line Systemic Treatment [Phase 2]
A Phase 2 clinical trial evaluating second-line systemic therapy in combination with SBRT for hepatocellular carcinoma with oligoprogression…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Clinical Study of VG161 in Subjects with Advanced Primary Liver Cancer [Phase 1]
A Phase 1 clinical study of VG161 for advanced primary liver cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Multi-mode Ablation and Molecular Imaging Multi-omics Study for Digestive-Origin Malignant Liver Tumors [NA]
This clinical trial from Fudan University investigates multi-mode ablation and molecular imaging with multi-omics for digestive-origin malig…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: TACE With Thermosensitive Nanogel Versus Embosphere for HCC [NA]
This clinical trial compares transarterial chemoembolization using a thermosensitive nanogel versus Embosphere embolization for unresectable…
-
CLINICAL_TRIALS research · 2024-09-05Clinical Trial Update: A Phase I Study of ERY974 in Patients With Hepatocellular Carcinoma [Phase 1]
Phase I clinical trial evaluating ERY974 in patients with hepatocellular carcinoma; the study is currently active but not recruiting.
-
CLINICAL_TRIALS withdrawal · 2024-09-04Clinical Trial Update: A Study of TAC-101 in Combination With TACE Versus TACE Alone in Asian Patients With Advanced Hepatocellular Carcinoma [Phase 2]
A Phase 2 trial evaluating TAC-101 in combination with transarterial chemoembolization (TACE) versus TACE alone in Asian patients with hepat…
-
CLINICAL_TRIALS trial_result · 2024-09-03Clinical Trial Update: Feasibility and Efficacy of Neoadjuvant Cabozantinib Plus Nivolumab (CaboNivo) Followed by Definitive Resection for Patients With Locally Advanced Hepatocellular Carcinoma (HCC) [Phase 1]
This Phase 1 study assessed the feasibility and preliminary efficacy of neoadjuvant cabozantinib plus nivolumab followed by definitive resec…
-
CLINICAL_TRIALS research · 2024-09-03Clinical Trial Update: Postoperative Adjuvant Therapy of Donafenib for Hepatocellular Carcinoma [NA]
This clinical trial update notes ongoing recruitment for postoperative adjuvant therapy with donafenib in hepatocellular carcinoma.
-
CLINICAL_TRIALS trial_result · 2024-09-03Clinical Trial Update: Regorafenib Followed by Nivolumab in Patients With Hepatocellular Carcinoma (GOING) [Phase 1, Phase 2]
The GOING trial assessed regorafenib followed by nivolumab in hepatocellular carcinoma across Phase 1 and Phase 2, and the study has complet…
-
CLINICAL_TRIALS withdrawal · 2024-08-29Clinical Trial Update: Treat-and-resect Study of Echo Decorrelation Imaging-controlled Radiofrequency Ablation in Liver Tumors [NA]
The treat-and-resect study of Echo Decorrelation Imaging–controlled Radiofrequency Ablation for liver tumors has been withdrawn.
-
CLINICAL_TRIALS research · 2024-08-29Clinical Trial Update: Title of Manuscript: Development and Internal-external Validation of a Comprehensive Model for Predicting Risk of Post-RFA Recurrence in HCC Patients
A clinical study aims to develop and validate a model to predict post-RFA recurrence in hepatocellular carcinoma patients. The trial is curr…